Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03070093
Title Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)
Recruitment Approved for marketing
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Astellas Pharma Global Development, Inc.
Indications

acute myeloid leukemia

Therapies

Gilteritinib

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
UCLA Los Angeles California 90095 United States Details
Rocky Mountain Cancer Center-M Aurora Colorado 80012 United States Details
Memorial Healthcare System Pembroke Pines Florida 33028 United States Details
Northside Hospital Atlanta Georgia 30342 United States Details
Georgia Cancer Center at Augusta University Augusta Georgia 30912 United States Details
Northwestern University Medical Center Chicago Illinois 60611 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis Indianapolis Indiana 45237 United States Details
Norton Cancer Institute Louisville Kentucky 40207 United States Details
Tulane University New Orleans Louisiana 70112 United States Details
University of Maryland Medical Center Baltimore Maryland 21201 United States Details
Johns Hopkins Hospital Baltimore Maryland 21287 United States Details
The Sidney Kimmel Comprehensive Cancer Center -Johns Hopkins University Baltimore Maryland 21287 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
West Michigan Regional Cancer Center Kalamazoo Michigan 49007 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
New Mexico Cancer Care Alliance Albuquerque New Mexico 87106 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Memorial Sloan Kettering New York New York 10021 United States Details
Weill Cornell Medical College New York New York 10065 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Wake Forest Baptist Hospital Winston-Salem North Carolina 27157 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
Penn State Hershey Medical Center Hershey Pennsylvania 17033 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19066 United States Details
UPCI Pittsburgh Pennsylvania 15232 United States Details
Vanderbilt University Nashville Tennessee 37232 United States Details
Huntsman Cancer Institute University of Utah Salt Lake City Utah 84112 United States Details
WVU Medicine Cancer Morgantown West Virginia 26506 United States Details
Site CA15002 Halifax Nova Scotia Canada Details
Site CA15003 Toronto Ontario Canada Details
Site CA15001 Montreal Quebec H1T 2M4 Canada Details
Site CA15005 Vancouver Canada Details
Site JP81001 Nagoya Aichi Japan Details
Site JP81002 Shinagawa-ku Tokyo Japan Details
Site JP81003 Fukuoka Japan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field